USPTO serial 79395753
BIOMODAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 27, 2026
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOMODAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPPO Box 34385Washington, DC 20043-9998United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for diagnostic use, all for scientific research purposes; diagnostic preparations for scientific research purposes; diagnostic preparations for scientific or research use other than for medical use; reagents for scientific research use; chemical reagents for scientific purposes; chemicals for use in scientific epigenetic research; chemicals for use in scientific analysis, other than medical or veterinary use; chemicals for use in the preparation and analysis of DNA and DNA extracts for use in science; chemical preparations to oxidate and bisulfite DNA extracts for use in science; PCR (Polymerase Chain Reaction) reagents for scientific and research use; nucleic acid sequences, namely, DNA primers, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; biomolecule labelling kits comprising reagents for use in scientific research; diagnostic preparations for medical research purposes; reagents for medical research use; chemical preparations for use in medical epigenetic research; clinical and medical diagnostic reagents for medical research purposes; chemicals for use in the preparation and analysis of DNA and DNA extracts for medical research purposes; PCR (Polymerase Chain Reaction) reagents for medical research purposes; nucleic acid sequences, namely, DNA primers for medical research purposes; all for medical research purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for use in the identification of genetic and epigenetic markers and the diagnosis and treatment of diseases or conditions that are caused by or exacerbated by genetic or epigenetic factors; chemical and biological preparations for medical or veterinary purposes for use in the identification of genetic and epigenetic markers and the diagnosis and treatment of diseases or conditions that are caused by or exacerbated by genetic or epigenetic factors; diagnostic substances for medical and veterinary use; preparations for detecting mutations in genes and genetic predispositions for medical or veterinary purposes; stem cells for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; all the aforesaid being diagnostic preparations for medical purposes used by medical laboratories | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, test tubes, PCR plates and sample collection equipment, namely, wipes and swabs for use in diagnostic testing, not for medical purposes; scientific research and laboratory apparatus, educational apparatus and simulators, namely, laboratory apparatus for analysing genetic and epigenetic sequences; scientific apparatus and instruments, namely, laboratory apparatus and instruments for extracting, purifying, modifying, amplifying and sequencing DNA for the analysis of DNA and other biological materials, not for medical purposes; diagnostic testing apparatus and instruments, namely, laboratory apparatus for the sequencing of DNA samples; apparatus and instruments for genetic analysis, namely, laboratory devices for detecting genetic and epigenetic sequences; downloadable computer programs for analysing genetic sequences and DNA analysis, downloadable computer programs for analysing epigenetic sequences and DNA analysis, downloadable software for scientific analysis of genetic sequences, downloadable software for scientific analysis of epigenetic sequences and downloadable databases all relating to the fields of genetics and DNA analysis; downloadable computer software for analysing DNA and other biological materials; parts and fittings for all the aforesaid goods, namely, structural parts and fittings for scientific apparatus and instruments for testing, analysing, identifying, sequencing and measuring DNA samples | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments, namely, medical diagnostic apparatus for testing DNA samples; apparatus for clinical diagnosis used to identify, sequence and measure DNA; medical diagnostic apparatus for the detection of mutations in genes and genetic predispositions; medical test kits comprising medical sample tubes, medical vials, medical diagnostic reagents, electrical sensors, optical sensors, and chemical sensors for the detection of mutations in genes and genetic predispositions; apparatus for taking blood samples; blood testing apparatus; parts and fittings for all the aforesaid goods, namely, structural parts and fittings for medical diagnostic apparatus and instruments for testing, analysing, identifying, sequencing and measuring DNA samples | ACTIVE | — |
| 042 | Scientific and technological services, namely, medical and veterinary research and DNA analysis services for scientific research purposes; industrial analysis and research services, namely, industrial DNA analysis services for scientific research purposes; research and development in the field of biotechnology, biology and chemistry; scientific investigations for medical purposes; scientific laboratory services; scientific research; scientific research and analysis in the field of identification of genetic and epigenetic markers and the diagnosis and treatment of diseases with a genetic component; scientific research and development; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics and genetic engineering; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to chemistry; scientific research relating to genetics; scientific research relating to genetics of plants; scientific research services; scientific services, namely, scientific laboratory services; scientific services and research relating thereto, namely, DNA analysis and screening relating to the processing of DNA samples and analysis of DNA sequencing data; scientific testing services, namely, genetic and epigenetic testing for scientific research purposes; DNA screening for scientific research purposes; pharmaceutical research and development; scientific research and development services in the field of genetics including epigenetics; genome research, namely genetic scientific research and epigenetic scientific research; stem cell research; gene therapy research; genetic engineering services; genetic and epigenetic DNA analysis services for scientific research purposes; DNA methylation and DNA hydroxymethylation analysis services for scientific research purposes; nucleic acid sequence analysis; research services for the development of new products; design and development of computer hardware and software; design and development of computer hardware and software in the field of genetic and epigenetic services; provision of information and data relating to medical and veterinary research and development, namely, providing information about medical research and providing information relating to veterinary research; software as a service (SaaS) services featuring software for the analysis of DNA and other biological materials; software as a service (SaaS) services featuring software for scientific analysis relating to the fields of genetics and DNA analysis; provision of temporary use of non-downloadable computer software for the analysis of DNA and other biological materials; provision of temporary use of non-downloadable computer software for scientific analysis relating to the fields of genetics and DNA analysis; professional consultancy and advisory services relating to all of the aforementioned services, namely, medical research advice and scientific research consultancy | ACTIVE | — |
| 044 | Medical and veterinary services; medical and veterinary services relating to DNA, genetics and genetic testing; medical clinic, medical and surgical diagnostic services; personalised medical services tailored to patients based on genetic or other information; health care; medical and healthcare clinic services; physical therapy; pharmaceutical advice; hospitals being hospital services; medical equipment rental; professional consultancy and advisory services relating to all of the aforementioned services in the field of healthcare | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biomodal Limited
- Other trademarks owned by Biomodal Limited
- Other trademarks owned by Biomodal Limited
- Other trademarks owned by Cambridge Epigenetix Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIOMODAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 4, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 3, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 27, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 27, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 27, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2025 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 25, 2025 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 6, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 6, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 7, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 7, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 7, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 8, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 8, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 8, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 28, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 28, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |